These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26833332)

  • 1. CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation.
    Jansen JC; Cirak S; van Scherpenzeel M; Timal S; Reunert J; Rust S; Pérez B; Vicogne D; Krawitz P; Wada Y; Ashikov A; Pérez-Cerdá C; Medrano C; Arnoldy A; Hoischen A; Huijben K; Steenbergen G; Quelhas D; Diogo L; Rymen D; Jaeken J; Guffon N; Cheillan D; van den Heuvel LP; Maeda Y; Kaiser O; Schara U; Gerner P; van den Boogert MA; Holleboom AG; Nassogne MC; Sokal E; Salomon J; van den Bogaart G; Drenth JP; Huynen MA; Veltman JA; Wevers RA; Morava E; Matthijs G; Foulquier F; Marquardt T; Lefeber DJ
    Am J Hum Genet; 2016 Feb; 98(2):310-21. PubMed ID: 26833332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation.
    Jansen JC; Timal S; van Scherpenzeel M; Michelakakis H; Vicogne D; Ashikov A; Moraitou M; Hoischen A; Huijben K; Steenbergen G; van den Boogert MA; Porta F; Calvo PL; Mavrikou M; Cenacchi G; van den Bogaart G; Salomon J; Holleboom AG; Rodenburg RJ; Drenth JP; Huynen MA; Wevers RA; Morava E; Foulquier F; Veltman JA; Lefeber DJ
    Am J Hum Genet; 2016 Feb; 98(2):322-30. PubMed ID: 26833330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCDC115-CDG: A new rare and misleading inherited cause of liver disease.
    Girard M; Poujois A; Fabre M; Lacaille F; Debray D; Rio M; Fenaille F; Cholet S; Ruel C; Caussé E; Selves J; Bridoux-Henno L; Woimant F; Dupré T; Vuillaumier-Barrot S; Seta N; Alric L; de Lonlay P; Bruneel A
    Mol Genet Metab; 2018 Jul; 124(3):228-235. PubMed ID: 29759592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation.
    Kodera H; Ando N; Yuasa I; Wada Y; Tsurusaki Y; Nakashima M; Miyake N; Saitoh S; Matsumoto N; Saitsu H
    Clin Genet; 2015 May; 87(5):455-60. PubMed ID: 24784932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone mineralization by regulating post-Golgi protein transport and glycosylation.
    Ashikov A; Abu Bakar N; Wen XY; Niemeijer M; Rodrigues Pinto Osorio G; Brand-Arzamendi K; Hasadsri L; Hansikova H; Raymond K; Vicogne D; Ondruskova N; Simon MEH; Pfundt R; Timal S; Beumers R; Biot C; Smeets R; Kersten M; Huijben K; ; Linders PTA; van den Bogaart G; van Hijum SAFT; Rodenburg R; van den Heuvel LP; van Spronsen F; Honzik T; Foulquier F; van Scherpenzeel M; Lefeber DJ; ; Mirjam W; Han B; Helen M; Helen M; Peter VH; Jiddeke VK; Diego M; Lars M; Katja BH; Jozef H; Majid A; Kevin C; Johann TWN
    Hum Mol Genet; 2018 Sep; 27(17):3029-3045. PubMed ID: 29878199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa.
    Van Damme T; Gardeitchik T; Mohamed M; Guerrero-Castillo S; Freisinger P; Guillemyn B; Kariminejad A; Dalloyaux D; van Kraaij S; Lefeber DJ; Syx D; Steyaert W; De Rycke R; Hoischen A; Kamsteeg EJ; Wong SY; van Scherpenzeel M; Jamali P; Brandt U; Nijtmans L; Korenke GC; Chung BHY; Mak CCY; Hausser I; Kornak U; Fischer-Zirnsak B; Strom TM; Meitinger T; Alanay Y; Utine GE; Leung PKC; Ghaderi-Sohi S; Coucke P; Symoens S; De Paepe A; Thiel C; Haack TB; Malfait F; Morava E; Callewaert B; Wevers RA
    Am J Hum Genet; 2017 Feb; 100(2):216-227. PubMed ID: 28065471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.
    Ng BG; Sosicka P; Fenaille F; Harroche A; Vuillaumier-Barrot S; Porterfield M; Xia ZJ; Wagner S; Bamshad MJ; Vergnes-Boiteux MC; Cholet S; Dalton S; Dell A; Dupré T; Fiore M; Haslam SM; Huguenin Y; Kumagai T; Kulik M; McGoogan K; Michot C; Nickerson DA; Pascreau T; Borgel D; Raymond K; Warad D; ; Flanagan-Steet H; Steet R; Tiemeyer M; Seta N; Bruneel A; Freeze HH
    Am J Hum Genet; 2021 Jun; 108(6):1040-1052. PubMed ID: 33964207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM165 deficiency causes a congenital disorder of glycosylation.
    Foulquier F; Amyere M; Jaeken J; Zeevaert R; Schollen E; Race V; Bammens R; Morelle W; Rosnoblet C; Legrand D; Demaegd D; Buist N; Cheillan D; Guffon N; Morsomme P; Annaert W; Freeze HH; Van Schaftingen E; Vikkula M; Matthijs G
    Am J Hum Genet; 2012 Jul; 91(1):15-26. PubMed ID: 22683087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sec7p directs the transitions required for yeast Golgi biogenesis.
    Deitz SB; Rambourg A; Képès F; Franzusoff A
    Traffic; 2000 Feb; 1(2):172-83. PubMed ID: 11208097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation.
    Vajro P; Zielinska K; Ng BG; Maccarana M; Bengtson P; Poeta M; Mandato C; D'Acunto E; Freeze HH; Eklund EA
    Orphanet J Rare Dis; 2018 Jan; 13(1):4. PubMed ID: 29321044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recurrent missense variant in SLC9A7 causes nonsyndromic X-linked intellectual disability with alteration of Golgi acidification and aberrant glycosylation.
    Khayat W; Hackett A; Shaw M; Ilie A; Dudding-Byth T; Kalscheuer VM; Christie L; Corbett MA; Juusola J; Friend KL; Kirmse BM; Gecz J; Field M; Orlowski J
    Hum Mol Genet; 2019 Feb; 28(4):598-614. PubMed ID: 30335141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation.
    Ferreira CR; Xia ZJ; Clément A; Parry DA; Davids M; Taylan F; Sharma P; Turgeon CT; Blanco-Sánchez B; Ng BG; Logan CV; Wolfe LA; Solomon BD; Cho MT; Douglas G; Carvalho DR; Bratke H; Haug MG; Phillips JB; Wegner J; Tiemeyer M; Aoki K; ; ; Nordgren A; Hammarsjö A; Duker AL; Rohena L; Hove HB; Ek J; Adams D; Tifft CJ; Onyekweli T; Weixel T; Macnamara E; Radtke K; Powis Z; Earl D; Gabriel M; Russi AHS; Brick L; Kozenko M; Tham E; Raymond KM; Phillips JA; Tiller GE; Wilson WG; Hamid R; Malicdan MCV; Nishimura G; Grigelioniene G; Jackson A; Westerfield M; Bober MB; Gahl WA; Freeze HH
    Am J Hum Genet; 2018 Oct; 103(4):553-567. PubMed ID: 30290151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.
    Larsen LE; van den Boogert MAW; Rios-Ocampo WA; Jansen JC; Conlon D; Chong PLE; Levels JHM; Eilers RE; Sachdev VV; Zelcer N; Raabe T; He M; Hand NJ; Drenth JPH; Rader DJ; Stroes ESG; Lefeber DJ; Jonker JW; Holleboom AG
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):583-597. PubMed ID: 34626841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II.
    Foulquier F; Vasile E; Schollen E; Callewaert N; Raemaekers T; Quelhas D; Jaeken J; Mills P; Winchester B; Krieger M; Annaert W; Matthijs G
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3764-9. PubMed ID: 16537452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing ER and Golgi N-glycosylation process using metabolic labeling in mammalian cultured cells.
    Péanne R; Vanbeselaere J; Vicogne D; Mir AM; Biot C; Matthijs G; Guérardel Y; Foulquier F
    Methods Cell Biol; 2013; 118():157-76. PubMed ID: 24295306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golgi function and dysfunction in the first COG4-deficient CDG type II patient.
    Reynders E; Foulquier F; Leão Teles E; Quelhas D; Morelle W; Rabouille C; Annaert W; Matthijs G
    Hum Mol Genet; 2009 Sep; 18(17):3244-56. PubMed ID: 19494034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegeneration.
    Davids M; Kane MS; He M; Wolfe LA; Li X; Raihan MA; Chao KR; Bone WP; Boerkoel CF; Gahl WA; Toro C
    J Med Genet; 2016 Mar; 53(3):180-9. PubMed ID: 26668131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for neo1p in retrograde transport from the Golgi complex to the endoplasmic reticulum.
    Hua Z; Graham TR
    Mol Biol Cell; 2003 Dec; 14(12):4971-83. PubMed ID: 12960419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia.
    Bolar NA; Golzio C; Živná M; Hayot G; Van Hemelrijk C; Schepers D; Vandeweyer G; Hoischen A; Huyghe JR; Raes A; Matthys E; Sys E; Azou M; Gubler MC; Praet M; Van Camp G; McFadden K; Pediaditakis I; Přistoupilová A; Hodaňová K; Vyleťal P; Hartmannová H; Stránecký V; Hůlková H; Barešová V; Jedličková I; Sovová J; Hnízda A; Kidd K; Bleyer AJ; Spong RS; Vande Walle J; Mortier G; Brunner H; Van Laer L; Kmoch S; Katsanis N; Loeys BL
    Am J Hum Genet; 2016 Jul; 99(1):174-87. PubMed ID: 27392076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring endoplasmic reticulum-to-Golgi traffic of a plant calreticulin by protein glycosylation analysis.
    Navazio L; Miuzzo M; Royle L; Baldan B; Varotto S; Merry AH; Harvey DJ; Dwek RA; Rudd PM; Mariani P
    Biochemistry; 2002 Dec; 41(48):14141-9. PubMed ID: 12450377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.